Comparing Brilinta vs Ticagrelor
Brilinta | Ticagrelor |
|
---|
Brilinta (ticagrelor) | Ticagrelor |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Brilinta blocks a substance called ADP (adenosine-5-diphosphate) which plays a crucial role in blood clotting and may be given together with aspirin to people who have had a heart attack or with... View more |
Prescription only
Prescribed for Coronary Artery Disease, Heart Attack, Acute Coronary Syndrome, Cardiovascular Risk Reduction, Ischemic Stroke - Prophylaxis, Myocardial Infarction - Prophylaxis, Prevention of... View more |
Related suggestions Cardiovascular Risk Reduction
Heart Attack (Myocardial Infarction)
Acute Coronary Syndrome
Ischemic Stroke, Prophylaxis
|
|||||||
More about Brilinta (ticagrelor) | More about Ticagrelor | ||||||||
Generic Status | |||||||||
No lower-cost generic available |
No lower-cost generic available |
||||||||
Ratings & Reviews | |||||||||
Brilinta has an average rating of 3.5 out of 10 from a total of 96 ratings on Drugs.com. 15% of reviewers reported a positive effect, while 62% reported a negative effect. |
Ticagrelor has an average rating of 3.7 out of 10 from a total of 110 ratings on Drugs.com. 15% of reviewers reported a positive effect, while 60% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
Common side effects include:
See also: Brilinta side effects in more detail. |
Commonly reported side effects include:
See also: ticagrelor side effects in more detail. |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Brilinta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
Brilinta | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
12.8 hours |
12.8 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 461 drugs are known to interact with Brilinta:
|
A total of 461 drugs are known to interact with ticagrelor:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
July 20, 2011 |
July 20, 2011 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.